Peter Hau

40PUBLICATIONS
119CO-AUTHORS
Predictive and prognostic markersMining, energy and natural resources lawMedical infection agents (incl. prions)ChiropracticGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 25, 2026
Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.

|Dec 01, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.

Howard Colman, Giuseppe Lombardi, Eric T Wong

|Aug 22, 2025
MRI-defined patterns of infiltration and outcome in patients with glioblastoma.

Katrin Scheu, Edith Vandieken, Katharina Hense

|Jun 09, 2025
Exploring spirituality in everyday neuro-oncology practice - nurses' and physicians' spiritual care toolbox.

Daniela Völz, Reinhard Grabenweger, Megan C Best

|Apr 22, 2025
Temporal Muscle Thickness as a Prognostic Marker in a Real-Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma: A Multicentric Imaging Analysis.

Lazaros Lazaridis, Christoph Moenninghoff, Elisabeth Bumes

|Dec 02, 2024
Targeted agents in patients with progressive glioblastoma-A systematic meta-analysis of randomized clinical trials.

Franziska Maria Ippen, Angelika Scherm, Tobias Kessler

Pageof 7

Frequent Collaborators

11 joint publications

Elisabeth Bumes

5 joint publications

Nils-Ole Schmidt

5 joint publications

Tareq M Haedenkamp

4 joint publications

Corinna Seliger-Behme